CTIS HIGHLIGHTS
Page 2 Issue 5 HIGHLIGHTS October 2021 CTIS A phased rollout of the training environment, structured in three waves is foreseen: Wave 1 (15 October 2021): access provided to Member State Master Trainers and their related users Wave 2 (Mid-November 2021): access provided to Sponsor Master Trainers and their related users (Batch 1); access provided to other sponsor …
Download CTIS HIGHLIGHTS
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
Code of Standard Practice - CISC-ICCA
cisc-icca.caThe CISC Code of Standard Practice for Structural Steel is a compilation of usual industry practices relating to the design, fabrication and erection of structural steel. These practices evolve over a period of time and are subject to change as improved methods replace those of …
CHARITIES SECTOR 2021 / 2022 CALL FOR APPLICATIONS ...
nlcsa.org.zaa guideline on the possible line items that can be considered for funding). 3.3 Please provide a motivation for the budget items requested (Tables 5.2 and 5.3) as well as for the project / programme applied for (Section 11) on the template provided. Failure to explicitly motivate for a budget item in the
Mine Health and Safety Act: Guidelines for Mandatory Code ...
www.gov.zaGUIDELINE FOR THE COMPILATION OF A MANDATORY CODE OF PRACTICE FOR THE MITIGATION AND MANAGEMENT OF COVID-19 OUTBREAK _____ Chief Inspector of Mines DATE: 18 MAY 2020 . Tis gaette is also availale free online at .gonline.co.a 6 No. 43335 GOVERNMENT GAZETTE, 18 ...
Company SHE Plan
www.novaserve.co.zaThis SHE Plan is prepared to provide NOVA Plant Services personnel with a comprehensive guideline ... Work must be supplied to NOVA Plant Services before the compilation of the SHE File. 3. Laws, Regulations & Requirements ... mandatory. The program will remain in place from the start of mobilisation through project completion.